Cargando…

Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions

BACKGROUND: Colorectal cancer (CRC) is the second leading cause of death among cancers in the United States. Although individuals diagnosed early have a greater than 90 % chance of survival, more than one-third of individuals do not adhere to screening recommendations partly because the standard dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Baxter, Nielson T., Ruffin, Mack T., Rogers, Mary A. M., Schloss, Patrick D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823848/
https://www.ncbi.nlm.nih.gov/pubmed/27056827
http://dx.doi.org/10.1186/s13073-016-0290-3
_version_ 1782425993697296384
author Baxter, Nielson T.
Ruffin, Mack T.
Rogers, Mary A. M.
Schloss, Patrick D.
author_facet Baxter, Nielson T.
Ruffin, Mack T.
Rogers, Mary A. M.
Schloss, Patrick D.
author_sort Baxter, Nielson T.
collection PubMed
description BACKGROUND: Colorectal cancer (CRC) is the second leading cause of death among cancers in the United States. Although individuals diagnosed early have a greater than 90 % chance of survival, more than one-third of individuals do not adhere to screening recommendations partly because the standard diagnostics, colonoscopy and sigmoidoscopy, are expensive and invasive. Thus, there is a great need to improve the sensitivity of non-invasive tests to detect early stage cancers and adenomas. Numerous studies have identified shifts in the composition of the gut microbiota associated with the progression of CRC, suggesting that the gut microbiota may represent a reservoir of biomarkers that would complement existing non-invasive methods such as the widely used fecal immunochemical test (FIT). METHODS: We sequenced the 16S rRNA genes from the stool samples of 490 patients. We used the relative abundances of the bacterial populations within each sample to develop a random forest classification model that detects colonic lesions using the relative abundance of gut microbiota and the concentration of hemoglobin in stool. RESULTS: The microbiota-based random forest model detected 91.7 % of cancers and 45.5 % of adenomas while FIT alone detected 75.0 % and 15.7 %, respectively. Of the colonic lesions missed by FIT, the model detected 70.0 % of cancers and 37.7 % of adenomas. We confirmed known associations of Porphyromonas assaccharolytica, Peptostreptococcus stomatis, Parvimonas micra, and Fusobacterium nucleatum with CRC. Yet, we found that the loss of potentially beneficial organisms, such as members of the Lachnospiraceae, was more predictive for identifying patients with adenomas when used in combination with FIT. CONCLUSIONS: These findings demonstrate the potential for microbiota analysis to complement existing screening methods to improve detection of colonic lesions. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13073-016-0290-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4823848
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48238482016-04-08 Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions Baxter, Nielson T. Ruffin, Mack T. Rogers, Mary A. M. Schloss, Patrick D. Genome Med Research BACKGROUND: Colorectal cancer (CRC) is the second leading cause of death among cancers in the United States. Although individuals diagnosed early have a greater than 90 % chance of survival, more than one-third of individuals do not adhere to screening recommendations partly because the standard diagnostics, colonoscopy and sigmoidoscopy, are expensive and invasive. Thus, there is a great need to improve the sensitivity of non-invasive tests to detect early stage cancers and adenomas. Numerous studies have identified shifts in the composition of the gut microbiota associated with the progression of CRC, suggesting that the gut microbiota may represent a reservoir of biomarkers that would complement existing non-invasive methods such as the widely used fecal immunochemical test (FIT). METHODS: We sequenced the 16S rRNA genes from the stool samples of 490 patients. We used the relative abundances of the bacterial populations within each sample to develop a random forest classification model that detects colonic lesions using the relative abundance of gut microbiota and the concentration of hemoglobin in stool. RESULTS: The microbiota-based random forest model detected 91.7 % of cancers and 45.5 % of adenomas while FIT alone detected 75.0 % and 15.7 %, respectively. Of the colonic lesions missed by FIT, the model detected 70.0 % of cancers and 37.7 % of adenomas. We confirmed known associations of Porphyromonas assaccharolytica, Peptostreptococcus stomatis, Parvimonas micra, and Fusobacterium nucleatum with CRC. Yet, we found that the loss of potentially beneficial organisms, such as members of the Lachnospiraceae, was more predictive for identifying patients with adenomas when used in combination with FIT. CONCLUSIONS: These findings demonstrate the potential for microbiota analysis to complement existing screening methods to improve detection of colonic lesions. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13073-016-0290-3) contains supplementary material, which is available to authorized users. BioMed Central 2016-04-06 /pmc/articles/PMC4823848/ /pubmed/27056827 http://dx.doi.org/10.1186/s13073-016-0290-3 Text en © Baxter et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Baxter, Nielson T.
Ruffin, Mack T.
Rogers, Mary A. M.
Schloss, Patrick D.
Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions
title Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions
title_full Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions
title_fullStr Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions
title_full_unstemmed Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions
title_short Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions
title_sort microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823848/
https://www.ncbi.nlm.nih.gov/pubmed/27056827
http://dx.doi.org/10.1186/s13073-016-0290-3
work_keys_str_mv AT baxternielsont microbiotabasedmodelimprovesthesensitivityoffecalimmunochemicaltestfordetectingcoloniclesions
AT ruffinmackt microbiotabasedmodelimprovesthesensitivityoffecalimmunochemicaltestfordetectingcoloniclesions
AT rogersmaryam microbiotabasedmodelimprovesthesensitivityoffecalimmunochemicaltestfordetectingcoloniclesions
AT schlosspatrickd microbiotabasedmodelimprovesthesensitivityoffecalimmunochemicaltestfordetectingcoloniclesions